Xiuli Yang
Immunology and Microbiology · Indiana University
Publications
143
Citations
4,356
Est. group size
—
Recurring co-author estimate
Active years
19
Publishing since 2007
Xiuli Yang's research centers on the microbiology and immunology of tick-borne infections, particularly the Lyme disease bacterium Borrelia burgdorferi. Work in this area examines how the pathogen evades the host immune system, how its genes are regulated, and how vaccines and protective proteins might be designed to prevent infection. The publication record also includes studies applying immunology and pharmacology methods to other topics such as cancer treatment and drug safety analysis.
Publication activity has fluctuated year to year but remains active, with output notably high in 2024 and averaging about 7 papers per year over the last five years.
Generated by claude-opus-4-8 from public bibliographic data · Jul 9, 2026
Typically publishes in teams of ~8 · 3% small-team papers (≤3 authors) · across 48 venues
- Nociceptor-derived CGRP enhances dermal type I conventional dendritic cell function to drive autoreactive CD8+ T cell responses in vitiligo
Immunity · 2025
- Safety assessment of proteasome inhibitors real world adverse event analysis from the FAERS database
Scientific Reports · 2025
- Mechanistic insights into the structure-based design of a CspZ-targeting Lyme disease vaccine
Nature Communications · 2025
- Borrelial phosphomannose isomerase as a cell surface localized protein that retains enzymatic activity and promotes host-pathogen interaction
mBio · 2025
- Cost-effectiveness analysis of eribulin versus dacarbazine in patients with advanced liposarcoma
Scientific Reports · 2025
- Complement therapeutic factor H-IgG proteins as pre-exposure prophylaxes against Lyme borreliae infections
The Journal of Immunology · 2025
- Long-Term Outcomes of Dose Escalation in Definitive Chemoradiotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma: A Multicenter, Randomized Phase III Trial
International Journal of Radiation Oncology*Biology*Physics · 2025
- MCP5, a methyl-accepting chemotaxis protein regulated by both the Hk1-Rrp1 and Rrp2-RpoN-RpoS pathways, is required for the immune evasion of Borrelia burgdorferi
bioRxiv (Cold Spring Harbor Laboratory) · 2024
- MCP5, a methyl-accepting chemotaxis protein regulated by both the Hk1-Rrp1 and Rrp2-RpoN-RpoS pathways, is required for the immune evasion of Borrelia burgdorferi
PLoS Pathogens · 2024
- BadR directly represses the expression of the glycerol utilization operon in the Lyme disease pathogen
Journal of Bacteriology · 2024
- The mechanism of action of <i>Botrychium (Thunb.) Sw.</i> for prevention of idiopathic pulmonary fibrosis based on 1H-NMR-based metabolomics
Journal of Pharmacy and Pharmacology · 2024
- Unveiling the charge transfer dynamics regulated by bonding evolution in single-atom Pt/C3N5 for boosting hydrogen evolution
Applied Catalysis B: Environmental · 2024
- Drug-Induced Gynecomastia: Data Mining and Analysis of the FDA Adverse Event Reporting System Database
Clinical Epidemiology · 2024
- Impact of E. muris infection on B. burgdorferi–induced joint pathology in mice
Frontiers in Immunology · 2024
- Real-world safety profile of zanubrutinib: a disproportionality analysis based on the FAERS database
BMJ Open · 2024
- bioRxiv (Cold Spring Harbor Laboratory)×8
- PMC×5
- Infection and Immunity×4
- Cellular Microbiology×4
- Scientific Reports×4
- Khemraj Budachetri
Immunology and Microbiology · The Ohio State University
- Risa Pesapane
Immunology and Microbiology · The Ohio State University
- Oghenekaro Omodior
Immunology and Microbiology · Indiana University
- Alexander Welker Biondo
Immunology and Microbiology · Purdue University West Lafayette
- Rory C. Chien
Immunology and Microbiology · The Ohio State University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Sep 1, 2026.
Claim or correct this profile